House of Commons Hansard Written Answers for 13 Jun 2005 (pt 28)

13 Jun 2005 : Column 107W—continued

NHS Staff (London)

Sarah Teather: To ask the Secretary of State for Health how many (a) clinical and (b) non-clinical NHS staff were employed in (i) Brent and (ii) each London primary care trust in each year since 1997. [2496]

Jane Kennedy: The number of clinical and non-clinical national health service staff employed in each constituency and primary care trust is not collected centrally. However, data collected by strategic health authority for the years 1997 to 2004 is available and has been placed in the Library.

Sarah Teather: To ask the Secretary of State for Health how many NHS dental nurses there were in (a) Brent and (b) each London primary care trust in each year since 1997. [2497]

Ms Rosie Winterton: Most national health service dentistry is provided by self-employed dentists, who employ their own dental nurses. As a result, information is not held centrally on numbers of dental nurses working in dental practices providing general dental services under the NHS.

No Secrets Guidance

Mr. Burstow: To ask the Secretary of State for Health if she will list local authorities in England which have established (a) adult protection policies and (b) adult protection committees following publication of the No Secrets guidance. [2910]

Mr. Byrne: Information on which local authorities in England have established adult protection committees will be available from the Commission for Social Care Inspection later this year.

Obesity

Sarah Teather: To ask the Secretary of State for Health how many children were diagnosed as obese in each London borough in each of the last five years. [2487]

Jane Kennedy: Figures for the numbers of children diagnosed as obese in each London borough are not collected centrally. However, figures on the prevalence of obesity are available by Government office region from the Health Survey for England. This data is available in table 5 on the Department's website at www.dh.gov.uk/assetRoot/04/10/94/11/0410941l.pdf.

Parliamentary Questions

David T.C. Davies: To ask the Secretary of State for Health when she expects to reply to the question tabled by the hon. Member for Monmouth for answer on 25 May, ref 1150. [3658]

13 Jun 2005 : Column 108W

Caroline Flint: A reply was sent to the hon. Member on Tuesday 7 June, Official Report, column 524W.

Pharmacies

Mr. Lansley: To ask the Secretary of State for Health what proportion of prescriptions in the United Kingdom are filled with a parallel traded product. [2287]

Jane Kennedy: The Department does not hold information on the proportion of prescriptions filled with a parallel imported medicine.

Sarah Teather: To ask the Secretary of State for Health how many pharmacies operated 24 hour services in each year since 1997 in (a) Brent East, (b) Brent and (c) each London primary care trust. [2529]

Jane Kennedy: Information on pharmacies operating 24 hour services is not collected centrally.

Sarah Teather: To ask the Secretary of State for Health how many pharmacies there were in each year since 1997 in (a) Brent East, (b) Brent and (c) each London primary care trust. [2530]

Jane Kennedy: Information on the number of community pharmacies by constituency is not collected centrally. However, information prior to 2002 is available by health authority (HA) and from 2002 by primary care trust (PCT). This data is shown in the tables.

Brent, East, Brent, North and Brent, South are currently served by Brent Teaching PCT, and were previously within Brent and Harrow HA. The remaining London PCTs sat in the following HAs.

Ealing, Hammersmith and Hounslow

Hillingdon

Kensington, Chelsea and Westminster

Barnet

Enfield and Haringey

Camden and Islington

Barking and Havering

East London and City

Redbridge and Waltham Forest

Bexley and Greenwich

Bromley

Lambeth, Southwark and Lewisham

Croydon

Kingston and Richmond

Merton, Sutton and Wandsworth

Table 1 shows the number of community pharmacies by HA prior to 2002. Table 2 shows the number of community pharmacies by PCT from 2002 onwards.
Table 1—By HA 1997 to 2002

Number of community pharmacies

HA 1997–98 1998–99 1999–2000 2000–01 2001–02

Brent and Harrow 136 134 131 130 129

Ealing, Hammersmith and Hounslow 168 165 166 163 161

Hillingdon 63 62 62 62 62

Kensington, Chelsea and Westminster 152 152 150 148 148

Barnet 79 79 79 79 n/a

Enfield and Haringey 117 117 116 116 ⁽²⁹⁾194

Camden and Islington 112 112 111 111 111

Barking and Havering 83 81 80 79 79

East London and City 169 169 169 167 166

Redbridge and Waltham Forest 109 109 109 108 108

Bexley and Greenwich 94 94 94 94 ⁽³⁰⁾151

Bromley 57 57 57 57 n/a

Lambeth, Southwark and Lewisham 178 176 176 174 174

Croydon 71 69 69 68 68

Kingston and Richmond 76 76 76 75 75

Merton, Sutton and Wandsworth 149 147 145 145 143

⁽²⁹⁾Barnet merged with Enfield and Haringey HA to become a single HA
⁽³⁰⁾Bromley merged with Bexley and Greenwich HA to become a single HA.

13 Jun 2005 : Column 109W

Table 2—By PCT 2002 to 2004

Number of community
pharmacies

Primary care trust 2002–03 2003–04

Brent Teaching 71 71

Ealing 69 70

Hammersmith and Fulham 41 40

Harrow 57 57

Hillingdon 62 62

Hounslow 50 50

Kensington and Chelsea 41 41

Westminster 106 105

Barnet 78 79

Camden 63 63

Islington 47 47

Enfield 59 59

Haringey 57 56

Barking and Dagenham 36 35

City and Hackney 65 65

Chingford, Wanstead and Woodford 23 ⁽³¹⁾n/a

Havering 43 43

Newham 60 60

Redbridge 39 50

Tower Hamlets 43 44

Walthamstow, Leyton and Leytonstone 46 ⁽³²⁾n/a

Waltham Forest n/a 58

Bexley 47 46

Bromley 57 57

Greenwich 47 48

Lambeth 59 58

Lewisham 52 52

Southwark 63 63

Croydon 68 68

Kingston 29 29

Richmond and Twickenham 45 45

Sutton and Merton 77 77

Wandsworth 65 67

⁽³¹⁾Chingford, Wanstead and Woodford PCT no longer exists.
⁽³²⁾Walthamstow, Leyton and Leytonstone PCT no longer exists.

	Number of community pharmacies
HA	1997–98	1998–99	1999–2000	2000–01	2001–02
Brent and Harrow	136	134	131	130	129
Ealing, Hammersmith and Hounslow	168	165	166	163	161
Hillingdon	63	62	62	62	62
Kensington, Chelsea and Westminster	152	152	150	148	148
Barnet	79	79	79	79	n/a
Enfield and Haringey	117	117	116	116	⁽²⁹⁾194
Camden and Islington	112	112	111	111	111
Barking and Havering	83	81	80	79	79
East London and City	169	169	169	167	166
Redbridge and Waltham Forest	109	109	109	108	108
Bexley and Greenwich	94	94	94	94	⁽³⁰⁾151
Bromley	57	57	57	57	n/a
Lambeth, Southwark and Lewisham	178	176	176	174	174
Croydon	71	69	69	68	68
Kingston and Richmond	76	76	76	75	75
Merton, Sutton and Wandsworth	149	147	145	145	143

	Number of community pharmacies
Primary care trust	2002–03	2003–04
Brent Teaching	71	71
Ealing	69	70
Hammersmith and Fulham	41	40
Harrow	57	57
Hillingdon	62	62
Hounslow	50	50
Kensington and Chelsea	41	41
Westminster	106	105
Barnet	78	79
Camden	63	63
Islington	47	47
Enfield	59	59
Haringey	57	56
Barking and Dagenham	36	35
City and Hackney	65	65
Chingford, Wanstead and Woodford	23	⁽³¹⁾n/a
Havering	43	43
Newham	60	60
Redbridge	39	50
Tower Hamlets	43	44
Walthamstow, Leyton and Leytonstone	46	⁽³²⁾n/a
Waltham Forest	n/a	58
Bexley	47	46
Bromley	57	57
Greenwich	47	48
Lambeth	59	58
Lewisham	52	52
Southwark	63	63
Croydon	68	68
Kingston	29	29
Richmond and Twickenham	45	45
Sutton and Merton	77	77
Wandsworth	65	67

Rheumatoid Arthritis

Lynne Featherstone: To ask the Secretary of State for Health if she will list the health (a) authorities and (b) trusts in England providing funding for anti-TNF therapy for people with rheumatoid arthritis; and if she will make a statement. [3072]

Mr. Byrne: The Department does not collect information on funding provided by strategic health authorities or primary care trusts for specific treatments.

Health bodies are obliged to fund, from general allocations, anti-TNF (tumour necrosis factor) treatment for those with severe rheumatoid arthritis who meet the clinical guidelines set by the National Institute for Health and Clinical Excellence.

13 Jun 2005 : Column 110W

Zoledronate

Mr. Lansley: To ask the Secretary of State for Health if she will make a statement on the availability of Zoledronate in the NHS to treat secondary bone cancer; and if she has plans to direct the National Institute for Health and Clinical Excellence to conduct an appraisal of the treatments available for the management of secondary bone cancer. [3447]

Ms Rosie Winterton: The number of prescriptions of Zoledronate (zoledronic acid) prescribed in the community in England since 2001 is shown in the table.

Prescriptions

2001 6

2002 35

2003 232

2004 314

	Prescriptions
2001	6
2002	35
2003	232
2004	314

Information on the hospital prescribing of this drug is not collected centrally.

Zoledronic acid belongs to the class of drug known as bisphosphonates and is licensed in the United Kingdom for the prevention of skeletal related events in patients with advanced malignancies involving bone and for the treatment of tumour-induced hypercalcaemia.

There are no plans to ask NICE to conduct an appraisal of bisphosphonates more generally.

Next Section

Index

Home Page